Io Therapeutics
Spring, US
Biotech
Founders & leadership
SL
Sharon LewExecutive Officer
SC
Sahani ChandraratnaDirector
VV
Vidyasagar VuligondaExecutive Officer
MS
Martin SandersExecutive Officer
Reported raises · per SEC filings
Form D private placements▶$4.2MraisedAug 2023 · 19 investors · BiotechnologyRule 506(b)
▶$4.2MraisedAug 2023 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sharon LewExecutive Officer
- Sahani ChandraratnaDirector
- Vidyasagar VuligondaExecutive Officer
- Martin SandersExecutive Officer
- Offering amount
- $4.2M
- Amount sold
- $4.2M
- First sale
- Feb 2023
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.